Hiromitsu Hayashi Selected Research

Hypercholesterolemia

1/2022	Statin as a therapeutic agent in gastroenterological cancer.
11/2016	Statin attenuates cell proliferative ability via TAZ (WWTR1) in hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiromitsu Hayashi Research Topics

Disease

76	Neoplasms (Cancer) 11/2022 - 11/2002
59	Hepatocellular Carcinoma (Hepatoma) 11/2022 - 11/2002
29	Neoplasm Metastasis (Metastasis) 01/2021 - 03/2005
9	Pancreatic Neoplasms (Pancreatic Cancer) 06/2022 - 09/2015
9	Liver Diseases (Liver Disease) 04/2021 - 01/2012
8	Lymphatic Metastasis 06/2022 - 03/2005
8	Adenocarcinoma 01/2022 - 12/2019
8	Cholangiocarcinoma 10/2021 - 11/2006
6	Kidney Diseases (Kidney Disease) 01/2020 - 08/2013
5	Hemorrhage 02/2022 - 05/2012
5	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 05/2011
5	Colonic Neoplasms (Colon Cancer) 09/2020 - 11/2012
4	Inflammation (Inflammations) 07/2022 - 12/2015
4	Sarcopenia 08/2019 - 04/2016
4	Thrombosis (Thrombus) 01/2019 - 03/2005
4	Hypertrophy 01/2019 - 09/2009
3	Disease Progression 02/2020 - 10/2013
3	Stomach Neoplasms (Stomach Cancer) 01/2020 - 12/2016
2	Wounds and Injuries (Trauma) 02/2022 - 12/2015
2	Surgical Wound Infection 02/2022 - 12/2015
2	Carcinoma (Carcinomatosis) 01/2022 - 01/2014
2	Hypercholesterolemia 01/2022 - 11/2016
2	Fibrosis (Cirrhosis) 01/2022 - 11/2014
2	Pathologic Constriction (Stenosis) 01/2022 - 09/2020
2	Carcinogenesis 12/2021 - 12/2015
2	Ascites 06/2021 - 02/2015
2	Virus Diseases (Viral Diseases) 04/2021 - 03/2014
2	Chronic Hepatitis C 04/2021 - 03/2014
2	Klatskin Tumor 09/2020 - 04/2020
2	Liver Abscess 08/2020 - 01/2018
2	Colorectal Neoplasms (Colorectal Cancer) 06/2020 - 10/2014
2	Neoplasm Micrometastasis 01/2020 - 01/2015
2	Residual Neoplasm 01/2020 - 01/2018
2	Primitive Neuroectodermal Tumors (PNET) 01/2019 - 09/2017
2	Abdominal Pain (Pain, Abdominal) 10/2017 - 11/2016
2	Rectal Neoplasms (Rectal Cancer) 06/2014 - 03/2005

Drug/Important Bio-Agent (IBA)

8	Tumor Biomarkers (Tumor Markers)IBA 03/2021 - 10/2010
8	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 03/2005
7	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020 - 03/2010
6	AntigensIBA 06/2022 - 12/2015
6	Proteins (Proteins, Gene)FDA Link 11/2021 - 01/2011
6	Biological ProductsIBA 04/2021 - 01/2012
6	Contrast MediaIBA 01/2020 - 08/2013
5	CarbohydratesIBA 01/2022 - 12/2015
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2014
4	Carcinoembryonic AntigenIBA 03/2021 - 10/2014
4	Leucovorin (Folinic Acid)FDA Link 12/2015 - 03/2010
3	Messenger RNA (mRNA)IBA 06/2022 - 02/2013
3	Capsules (Microcapsules)IBA 05/2022 - 11/2002
3	Pharmaceutical PreparationsIBA 01/2022 - 01/2014
3	BilirubinIBA 01/2022 - 03/2013
3	Human Serum Albumin FDA LinkGeneric 10/2021 - 05/2014
3	lentil lectinIBA 04/2021 - 01/2019
3	Gemcitabine FDA Link 02/2020 - 02/2014
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2020 - 01/2014
3	Sorafenib (BAY 43-9006)FDA Link 04/2018 - 05/2015
3	Anti-Bacterial Agents (Antibiotics)IBA 10/2017 - 06/2009
3	Therapeutic UsesIBA 03/2017 - 09/2007
2	Mevalonic Acid (Mevalonate)IBA 01/2022 - 11/2016
2	EnzymesIBA 01/2022 - 05/2020
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 11/2016
2	AlbuminsIBA 01/2022 - 11/2019
2	ElementsIBA 10/2021 - 07/2021
2	Keratins (Keratin)IBA 10/2021 - 01/2015
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 04/2021 - 02/2019
2	Histones (Histone)IBA 01/2021 - 12/2013
2	Bevacizumab (Avastin)FDA Link 06/2020 - 12/2015
2	SteroidsIBA 04/2020 - 06/2011
2	Serum AlbuminIBA 02/2020 - 12/2014
2	Small Interfering RNA (siRNA)IBA 01/2020 - 09/2015
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 11/2019 - 09/2014
2	Fetal Proteins (Fetoprotein)IBA 02/2019 - 01/2019
2	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 01/2018
2	Prothrombin (Factor II)IBA 01/2019 - 09/2017
2	Cadherins (E-Cadherin)IBA 09/2015 - 01/2013
2	Antiviral Agents (Antivirals)IBA 03/2015 - 03/2014
2	Enhancer of Zeste Homolog 2 ProteinIBA 02/2014 - 12/2013
2	VimentinIBA 01/2013 - 07/2012
2	Bile Acids and Salts (Bile Acids)IBA 12/2012 - 09/2009
1	PlasticsIBA 02/2022

Therapy/Procedure

45	Hepatectomy 11/2022 - 06/2010
35	Therapeutics 01/2022 - 11/2002
22	Drug Therapy (Chemotherapy) 06/2022 - 03/2005
12	Radiofrequency Ablation 05/2021 - 11/2002
7	Pancreaticoduodenectomy 01/2022 - 11/2014
4	Stents 02/2022 - 07/2004
4	Lymph Node Excision (Lymph Node Dissection) 04/2019 - 11/2008
3	Adjuvant Chemotherapy 06/2022 - 01/2019
3	Pancreatectomy 01/2022 - 07/2016
3	Length of Stay 09/2020 - 05/2012
3	Catheters 08/2020 - 11/2008
3	Punctures 01/2018 - 11/2006
3	Radiotherapy 11/2008 - 03/2005
2	Erythrocyte Transfusion 01/2022 - 01/2019
2	Laparotomy 01/2021 - 02/2015
2	Laparoscopic Cholecystectomy 04/2020 - 12/2015
2	Aftercare (After-Treatment) 12/2019 - 05/2015
2	Blood Transfusion (Blood Transfusions) 11/2019 - 07/2016
2	Gastrectomy 01/2018 - 11/2016
1	Activities of Daily Living (ADL) 11/2022